Author´s answer: Biosimilar therapy for inflammatory bowel disease
Rev Esp Enferm Dig
.
2014 Jan;106(1):67-8.
doi: 10.4321/s1130-01082014000100015.
Authors
Federico Argüelles-Arias
,
Manuel Barreiro-de-Acosta
,
Fernando Carballo
,
Joaquín Hinojosa
,
Teresa Tejerina
PMID:
24689723
DOI:
10.4321/s1130-01082014000100015
No abstract available
Publication types
Letter
Comment
MeSH terms
Biosimilar Pharmaceuticals / therapeutic use*
Humans
Inflammatory Bowel Diseases / drug therapy*
Substances
Biosimilar Pharmaceuticals